Globally, the burden of HIV disproportionately impacts developing countries. Women are particularly affected, representing 60% of HIV infections in the Sub-Saharan region1. There are favorable trends in HIV incidence in some countries, but considerable obstacles to controlling the disease persist. Current UW CFAR-affiliated research efforts including male circumcision, herpes suppression, microbicides and vaccine trials continue to contribute promising prevention techniques. Maximizing research capacity in resourcelimited settings requires ongoing support of infrastructure, human resources, technical training, and community engagement"""""""". Since its inception in 1995, the UW CFAR International Clinical and Prevention Research Core has worked to address these gaps and to promote effective HIV research in a global context. UW CFAR priority countries include Kenya and Peru. We also support CFAR-affiliated investigators working in Central America, Senegal, Mozambique, Uganda, China, India and the Caribbean. Currently, more than 78 UW CFARaffiliated faculty and fellows and 41 international investigators are actively involved in international research and training activities. The Center for AIDS Research, part of the wider UW Center for AIDS and STD, is a WHO/PAHO Collaborating Center for AIDS and STD. Mission: The UW CFAR International Core supports, facilitates and coordinates research on HIV/AIDS by University of Washington faculty in developing countries by providing research mentorship, logistical, operational and infrastructure support as well as small pilot grants. The Long-Term Goals of the International Core are to: Promote and facilitate HIV/AIDS research by UW CFAR-affiliated investigators in developing countries. Develop long-term, sustainable partnerships for HIV research and training in a focused set of developing country settings, enabling collaborating investigators and institutions in those countries to achieve greater independence with responsibilities and roles equivalent to those of the UW-based CFAR-affiliated faculty and institutions. Support innovative HIV/AIDS research in women and children in developing countries.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027757-25
Application #
8376316
Study Section
Special Emphasis Panel (ZAI1-EC-A)
Project Start
Project End
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
25
Fiscal Year
2012
Total Cost
$347,720
Indirect Cost
$104,513
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Coban, Hamza; Robertson, Kevin; Smurzynski, Marlene et al. (2017) Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen. AIDS 31:1565-1571
Goyette, Marielle S; Wilson, Kate S; Deya, Ruth et al. (2017) Brief Report: Association Between Menopause and Unprotected Sex in High-Risk HIV-Positive Women in Mombasa, Kenya. J Acquir Immune Defic Syndr 74:488-492
LaCourse, Sylvia M; Deya, Ruth W; Graham, Susan M et al. (2017) Evaluation of the Isoniazid Preventive Therapy Care Cascade Among HIV-Positive Female Sex Workers in Mombasa, Kenya. J Acquir Immune Defic Syndr 76:74-81
Dross, Sandra E; Munson, Paul V; Kim, Se Eun et al. (2017) Kinetics of Myeloid-Derived Suppressor Cell Frequency and Function during Simian Immunodeficiency Virus Infection, Combination Antiretroviral Therapy, and Treatment Interruption. J Immunol 198:757-766
Drozd, Daniel R; Saag, Michael S; Westfall, Andrew O et al. (2017) Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice. Medicine (Baltimore) 96:e6275
Dombrowski, Julia C; Bove, Joanna; Roscoe, James C et al. (2017) ""Out of Care"" HIV Case Investigations: A Collaborative Analysis Across 6 States in the Northwest US. J Acquir Immune Defic Syndr 74 Suppl 2:S81-S87
Mugwanya, Kenneth K; John-Stewart, Grace; Baeten, Jared (2017) Safety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women. Expert Opin Drug Saf 16:867-871
Puttkammer, Nancy; Domerçant, Jean Wysler; Adler, Michelle et al. (2017) ART attrition and risk factors among Option B+ patients in Haiti: A retrospective cohort study. PLoS One 12:e0173123
Koelle, David M; Norberg, Peter; Fitzgibbon, Matthew P et al. (2017) Worldwide circulation of HSV-2?×?HSV-1 recombinant strains. Sci Rep 7:44084
Barbee, Lindley A; Khosropour, Christine M; Dombrowksi, Julia C et al. (2017) New Human Immunodeficiency Virus Diagnosis Independently Associated With Rectal Gonorrhea and Chlamydia in Men Who Have Sex With Men. Sex Transm Dis 44:385-389

Showing the most recent 10 out of 1172 publications